Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Argyro, Lazarini"'
Autor:
Konstantinos Thomas, Argyro Lazarini, Evripidis Kaltsonoudis, Paraskevi V. Voulgari, Alexandros A. Drosos, Argyro Repa, Ainour Molla Ismail Sali, Prodromos Sidiropoulos, Panagiota Tsatsani, Sousana Gazi, Kalliopi Fragkiadaki, Maria G. Tektonidou, Petros P. Sfikakis, Pelagia Katsimbri, Dimitrios Boumpas, Evangelia Argyriou, Kyriaki A. Boki, Konstantina Karagianni, Christina Katsiari, Gerasimos Evangelatos, Alexios Iliopoulos, Eleftheria P. Grika, Panagiotis G. Vlachoyiannopoulos, Theodoros Dimitroulas, Alexandros Garyfallos, Konstantinos Melissaropoulos, Panagiotis Georgiou, Constantinos Georganas, Periklis Vounotrypidis, Konstantinos Ntelis, Maria Areti, George D. Kitas, Dimitrios Vassilopoulos
Publikováno v:
Frontiers in Medicine, Vol 9 (2023)
IntroductionPatients with rheumatoid arthritis (RA) are at increased risk for serious infections. Pneumococcal vaccination is among the most important preventive measures, however, vaccine uptake is suboptimal. We explored the rate and factors associ
Externí odkaz:
https://doaj.org/article/1b7a518de5de4e53badc589265562105
Autor:
Konstantinos Thomas, Emilia Hadziyannis, Chrisoula Hatzara, Anastasia Makris, Christina Tsalapaki, Argyro Lazarini, Kalliopi Klavdianou, Katerina Antonatou, Christos Koutsianas, Dimitrios Vassilopoulos
Publikováno v:
Pathogens and Immunity, Vol 5, Iss 1, Pp 34-51 (2020)
Background: To determine the conversion and reversion rates of tuberculosis (TB) screening tests (Tuberculin Skin Test-TST, Interferon Gamma Release Assay-IGRA: T-SPOT.TB) during biologic treatment in patients with rheumatic diseases and negative bas
Externí odkaz:
https://doaj.org/article/abc10e7f84d9442f8bde157b6092e1af
Autor:
George Athanasios Karpouzas, Eirik Ikdahl, Silvia Rollefstad, Grunde Wibetoe, Anne Grete Semb, Joseph Sexton, Patrick Durez, Maria G Tektonidou, Michal Tomčík, Dionicio Angel Galarza-Delgado, Ian Graham, Miguel A González-Gay, Solbritt Rantapää-Dahlqvist, Erkin M Mirrakhimov, Petros P Sfikakis, Virginia Pascual-Ramos, Carol Hitchon, Maria Simona Stoenoiu, Elena Myasoedova, Durga Prasanna Misra, Vikas Agarwal, Dimitrios Vassilopoulos, Piet van Riel, Bindee Kuriya, George Kitas, Rong Mu, Anne M Kerola, Karen Douglas, Andrew A Borg, Pompilio Faggiano, Cindy Crowson, Argyro Lazarini, Diane Gheta, Svetlana Myasoedova, Lev Krougly, Tatiana Valentinovna Popkova, Alena Tuchyňová, Michal Vrablik, Pavel Horak, Helena Kaspar Medkova
Publikováno v:
RMD Open, Vol 7, Iss 2 (2021)
Aim The objective was to examine the prevalence of atherosclerotic cardiovascular disease (ASCVD) and its risk factors among patients with RA with diabetes mellitus (RA-DM) and patients with RA without diabetes mellitus (RAwoDM), and to evaluate lipi
Externí odkaz:
https://doaj.org/article/9fd119c49877421cb94f10bf0d78fcbf
Autor:
Kalliopi Klavdianou, Argyro Lazarini, Alexandros Grivas, Dimitrios Tseronis, Christina Tsalapaki, Panagiota Rapsomaniki, Katerina Antonatou, Konstantinos Thomas, Dimitrios Boumpas, Pelagia Katsimbri, Dimitrios Vassilopoulos
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background: Real world evidence data regarding secukinumab (SEC) use in biologic-experienced patients with psoriatic arthritis (PsA) are scarce.Objectives: To assess the real life survival, safety and efficacy of SEC in biologic-experienced patients
Externí odkaz:
https://doaj.org/article/11f3f7a5fb934a7b8682fdc226facc45
Autor:
Elena Myasoedova, Svetlana Myasoedova, Dimitrios Vassilopoulos, Dionicio Ángel Galarza-Delgado, Solbritt Rantapää Dahlqvist, Maria G Tektonidou, Michal Vrablík, Cynthia S. Crowson, Virginia Pascual-Ramos, Bindee Kuriya, Miguel A. González-Gay, Diane Gheta, George Karpouzas, Michal Tomcik, Grunde Wibetoe, Lev B. Krougly, Carol A. Hitchon, Pavel Horák, Andrew A. Borg, Pompilio Faggiano, Argyro Lazarini, Petros P. Sfikakis, Anne Grete Semb, Joseph O. Sexton, Helena Medková, Durga Prasanna Misra, Maria Stoenoiu, Tatiana Popkova, Rong Mu, Silvia Rollefstad, Erkin M. Mirrakhimov, Ian D. Graham, Eirik Ikdahl, Jiri Lastuvka, Piet L. C. M. van Riel, George D. Kitas, Patrick Durez, Alena Tuchyňová
Publikováno v:
European Heart Journal-Cardiovascular Pharmacotherapy, 8, 6, pp. 539-548
European Heart Journal-Cardiovascular Pharmacotherapy, 8, 539-548
European Heart Journal-Cardiovascular Pharmacotherapy, 8, 539-548
Aims To assess differences in estimated cardiovascular disease (CVD) risk among rheumatoid arthritis (RA) patients from different world regions and to evaluate the management and goal attainment of lipids and blood pressure (BP). Methods and results
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::400fe423353929fe009cca2ec6890303
https://hdl.handle.net/2066/282732
https://hdl.handle.net/2066/282732
Autor:
Argyro Repa, Dimitrios Vassilopoulos, C. Georganas, Alexandros Garyfallos, M. Areti, Pelagia Katsimbri, Theodoros Dimitroulas, Evripidis Kaltsonoudis, Lazaros I. Sakkas, Alexandros A. Drosos, Argyriou Evangelia, Konstantinos Melissaropoulos, P. Vounotrypidis, Georgios Georgiopoulos, Gerasimos Evangelatos, S. Gazi, Dimitrios T. Boumpas, Eleftheria P. Grika, Prodromos Sidiropoulos, P. G. Vlachoyiannopoulos, Konstantina Karagianni, Kalliopi Fragkiadaki, P. Tsatsani, Maria G Tektonidou, Panagiotis Georgiou, Kyriaki A. Boki, Petros P. Sfikakis, Alexios Iliopoulos, Argyro Lazarini, Paraskevi V. Voulgari, Ainour Molla Ismail Sali, George D. Kitas, Konstantinos Thomas
Publikováno v:
Rheumatology. 60:2223-2230
Objectives Predicting serious infections (SI) in patients with rheumatoid arthritis (RA) is crucial for the implementation of appropriate preventive measures. Here we aimed to identify risk factors for SI and to validate the RA Observation of Biologi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e535be2c3c28b4d89d5a43ae8d40a4c3
https://doi.org/10.1093/rheumatology/keaa557
https://doi.org/10.1093/rheumatology/keaa557
Autor:
Constantinos Papadopoulos, Argyro Lazarini, Alexia Balanika, Ioannis Sofianos, Antonis Fanouriakis, Antonia Elezoglou, Eleni Bagiazidou
Publikováno v:
Rheumatology. 60:e378-e380
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f529d11f16ca7c4935c6bc7a34274696
https://doi.org/10.1093/rheumatology/keab422
https://doi.org/10.1093/rheumatology/keab422
Autor:
Anne Grete Semb, Silvia Rollefstad, Joseph Sexton, Eirik Ikdahl, Cynthia S. Crowson, Piet van Riel, George Kitas, Ian Graham, Anne M. Kerola, George Athanasios Karpouzas, Miguel A Gonzalez-Gay, Petros P Sfikakis, Maria G Tektonidou, Argyro Lazarini, Dimitrios Vassilopoulos, Bindee Kuriya, Carol Hitchon, Maria Simona Stoenoiu, Patrick Durez, Virginia Pascual-Ramos, Dionicio Angel Galarza-Delgado, Pompilio Faggiano, Durga Prasanna Misra, Andrew A Borg, Rong Mu, Erkin M Mirrakhimov, Diane Gheta, Karen Douglas, Vikas Agarwal, Svetlana Myasoedova, Lev Krougly, Tatiana Valentinovna Popkova, Alena Tuchyňová, Michal Tomcik, Michal Vrablik, Jiri Lastuvka, Pavel Horak, Helena Kaspar Medkova
Publikováno v:
International journal of cardiology. Heart & vasculature, 42
Objective: To describe the prevalence of atrial fibrillation (AF) in patients with rheumatoid arthritis (RA), and to evaluate the proportion of patients with AF receiving guideline-recommended anticoagulation for prevention of stroke, based on data f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0bcc7f38e4788c5ef81346a0f1a5c73
https://doi.org/10.1016/j.ijcha.2022.101117
https://doi.org/10.1016/j.ijcha.2022.101117
Autor:
Katerina Antonatou, D. Tseronis, Dimitrios Vassilopoulos, P. Rapsomaniki, Pelagia Katsimbri, Konstantinos Thomas, A. Grivas, Dimitrios T. Boumpas, Christina Tsalapaki, Kalliopi Klavdianou, Argyro Lazarini
Publikováno v:
Frontiers in Medicine
Frontiers in Medicine, Vol 7 (2020)
Frontiers in Medicine, Vol 7 (2020)
Background: Real world evidence data regarding secukinumab (SEC) use in biologic-experienced patients with psoriatic arthritis (PsA) are scarce. Objectives: To assess the real life survival, safety and efficacy of SEC in biologic-experienced patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3846992622a62cdd4452530c5caa0dbf
http://europepmc.org/articles/PMC7317305
http://europepmc.org/articles/PMC7317305
Publikováno v:
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy. 34(2)
Following the approval of belimumab, the first drug to be approved for systemic lupus erythematosus (SLE) in over 50 years, advances in our understanding of the pathogenesis of the disease have led to a remarkable number of clinical trials for invest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69112cae5c341eb4f15eafbf81d3135d
https://pubmed.ncbi.nlm.nih.gov/32002918
https://pubmed.ncbi.nlm.nih.gov/32002918